Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries

RATIONALE: Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in Europe. Reported treatment success rates are around 50% or less, and cure rates are even lower. OBJECTIVES: To document the management and treatment outcome in …

Multidrug resistant tuberculosis in Europe

Management of patients with MDR-TB in the TBnet clinical network.

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study

RATIONALE: In the absence of active tuberculosis, a positive tuberculin skin test (TST) or interferon-γ release assay (IGRA) result defines latent infection with Mycobacterium tuberculosis, although test results may vary depending on …